— Know what they know.
Not Investment Advice
Also trades as: PRM.L (LSE) · $vol 0M

PMSNF OTC

Proteome Sciences plc
1W: +0.0% 1M: +0.0% 3M: -50.0% YTD: -75.0% 1Y: -80.0% 3Y: -99.1%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Specialties · Tech Score Strong Sell · Power 38 · $2.9M mcap · 222M float · 0.0005% daily turnover · Short 88% of daily vol

Income Trends

Revenue
$5M -2.8% ▼
5Y CAGR: -81.0%
Gross Profit
$670K -59.3% ▼
5Y CAGR: -87.2%
Operating Income
-$2M -45.2% ▼
Net Income
-$3M -39.4% ▼
EPS (Diluted)
$-0.01 -38.6% ▼
EBITDA
-$2M -33.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$16.9B$22.6B$23.7B$5M$5M
YoY Growth-14.1%+33.3%+5.1%-100.0%-2.8%
Cost of Revenue$2M$2M$3M$3M$4M
Gross Profit$3M$3M$5M$2M$670K
Gross Margin0.0%0.0%0.0%32.8%13.7%
R&D Expenses$202K$287K$376K$637K$606K
SG&A Expenses$2M$2M$3M$3M$3M
Operating Expenses$2M$3M$3M$3M$3M
Operating Income$549K$412K$2M-$2M-$2M
Operating Margin0.0%0.0%0.0%-32.2%-48.1%
Interest Expense$304K$294K$473K$797K$895K
Income Before Tax$245K$118K$1M-$2M-$3M
Tax Expense-$50K$46K-$69K$25K$158K
Net Income$295K$72K$1M-$2M-$3M
Net Margin0.0%0.0%0.0%-48.6%-69.7%
EPS (Diluted)$0.00$0.00$0.00$-0.01$-0.01
EBITDA$714K$625K$2M-$1M-$2M
Shares Outstanding295M302M309M295M295M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms